Reader’s Guide to the Antimycin A  Docket # EPA-HQ-OPP-2006-1002

  

EPA has created this document to provide an organizational structure to
the Antimycin A docket.  The docket index lists the caption entries
sequentially, while this document lists them by subject matter.  The
Agency is providing the “Readers Guide” to allow the reader to more
easily access and navigate the various entries contained in the
Antimycin docket.

Phase 3 Federal Register and Docket Organizational Documents:  

Docket Entry 1.	Federal Register Notice: Antimycin A  Risk Assessments;
Notice of Availability, and Risk Reduction Options (Phase 3 of 4-Phase
Process)

Docket Entry 2.	Reader’s Guide to the Antimycin A Docket #
EPA-HQ-OPP-2006-1002

Docket Entry 3.	 Antimycin A:  Revised Health Effects Division (HED)
Considerations for the Reregistration Eligibility Decision (RED)
Document to address “Error” comments. 

Docket Entry 4.	Revised Environmental Fate and Ecological Risk
Assessment 

			Chapter (DP Barcode D310730) in Support of Phase III of the 

			Reregistration Eligibility  Decision on Antimycin A (PC 

	Code 006314)

Docket Entry 5.	Environmental Fate and Ecological Risk Assessment for
the Reregistration of Antimycin A.

Docket Enrty 6.	Alternatives Analysis for Antimycin A and Rotenone 

			in Lakes and Streams (DP# 310753 and 307400) 

Docket Entry 7.	Antimycin A Drinking Water Characterization (Revision 1)

Docket Entry 8.	Aquabiotics Response Cover Letter

Docket Entry 9.	Environmental Fate and Ecological Risk Assessment 
Chapter (DP Barcode D310733) in Support of Phase I of the Reregistration
Eligibility  Decision on Antimycin A (PC Code 006314)

Docket Entry 10.	Antimycin A:  Health Effects Division (HED)
Considerations for the Reregistration Eligibility Decision (RED)
Document.  Phase I.  	 

Docket Entry 11.	Antimycin A Drinking Water Characterization

Docket Entry 12.	Environmental Fate and Ecological Risk Assessment for
the Reregistration of Antimycin A. Aquabiotics Phase 1 Response EFED
Chapter 

		

Reader’s Guide:  Antimycin A

CRM:  Lance Wormell

EPA/OPPTS/OPP/SRRD

 PAGE   

